journal article Jan 01, 2022

GRP75-faciliated Mitochondria-associated ER Membrane (MAM) Integrity controls Cisplatin-resistance in Ovarian Cancer Patients

View at Publisher Save 10.7150/ijbs.71571
Metrics
87
Citations
0
References
Details
Published
Jan 01, 2022
Vol/Issue
18(7)
Pages
2914-2931
Cite This Article
Jing Li, Fangzheng Qi, Huishan Su, et al. (2022). GRP75-faciliated Mitochondria-associated ER Membrane (MAM) Integrity controls Cisplatin-resistance in Ovarian Cancer Patients. International Journal of Biological Sciences, 18(7), 2914-2931. https://doi.org/10.7150/ijbs.71571
Related

You May Also Like

Risk Factors and Preventions of Breast Cancer

Yi-Sheng Sun, Zhao Zhao · 2017

1,436 citations

The PI3K/AKT pathway in obesity and type 2 diabetes

Xingjun Huang, Guihua Liu · 2018

1,408 citations

The role of TGF-β/SMAD4 signaling in cancer

Ming Zhao, Lopa Mishra · 2018

533 citations